Further supporting the early immune activation in LS, normal colonic mucosa specimens from cancer-free patients were shown to be highly infiltrated by immune cells, including CD45+, CD8+, natural killer (NK), dendritic, mast, and B-cell populations, at even greater levels than tumor-distant normal colonic mucosa of LS patients with CRC (49). The gene discussed is CD8A; the disease is cancer.